GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

2,201.00p
   
  • Change Today:
      34.00p
  • 52 Week High: 2,268.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,072.56m
  • Volume: 13,807,652
  • Market Cap: £89,637m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

GSK secures Japan and China reviews for two late‑stage liver disease treatments

By Iain Gilbert

Date: Thursday 26 Feb 2026

(Sharecast News) - Drugmaker GSK said on Thursday that regulators in Japan and China had accepted two separate new drug applications for review, covering investigational treatments targeting chronic hepatitis B and cholestatic pruritus in primary biliary cholangitis.

GSK ShareCast News

Director/PDMR Shareholding 25-Feb-2026 ShareCast
GSK to acquire Canada's 35Pharma for $950m 25-Feb-2026 ShareCast
GSK's Exdensur gets green light from European Co... 17-Feb-2026 ShareCast
China's CDE accepts GSK's regulatory filing for ... 10-Feb-2026 ShareCast
JP Morgan raises target price on GSK 09-Feb-2026 ShareCast

GSK Regulatory News

Director/PDMR Shareholding 27-Feb-2026 15:30 RNS
Transaction in Own Shares 27-Feb-2026 07:00 RNS
Linerixibat accepted for priority review in China 26-Feb-2026 07:05 RNS
Linerixibat accepted for priority review in China 26-Feb-2026 07:05 RNS
Bepirovirsen accepted for Japan regulatory review 26-Feb-2026 07:00 RNS

GSK Newspaper Links

GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph
GlaxoSmithKline tops table in effort to get drug... 17-Nov-2014 Guardian

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 2,201.00p
Change Today 34.00p
% Change 1.57 %
52 Week High 2,268.00
52 Week Low 1,264.00
Volume 13,807,652
Shares Issued 4,072.56m
Market Cap £89,637m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 19-Feb-26 13-Nov-25
Paid 09-Apr-26 08-Jan-26
Amount 18.00p 16.00p

Trades for 27-Feb-2026

Time Volume / Share Price
16:24 1 @ 2,197.00p
16:20 0 @ 2,194.00p
15:43 1 @ 2,191.00p
15:42 0 @ 2,191.00p
15:28 0 @ 2,187.00p

GSK Key Personnel

CEO Luke Miels

Top of Page